Patents

  • Patent Number Year Symeres Authors Customer
    Piperidinylpyrazolopyrimidinones and their use WO2016071216A1 2016 Jörg Heiermann, Willem Hengelveld Bayer Pharma

    Read more

  • Patent Number Year Symeres Authors Customer
    Multiple D2 a(nta)gonists/H3 antagonists for treatment of CNS-related disorders WO 2015/069110 A1 2015 André Heeres, Mark Borst AAPA B.V.

    Read more

  • Patent Number Year Symeres Authors Customer
    Pesticidally active heterocyclic derivatives with sulphur containing substituents WO2015/144826 A1WO2015/144895 A1WO2016/113155 A1WO2016/012395 A1WO2017/016922 A1WO2017/050751 A1 2015 Ruud Titulaer Syngenta

    Read more

  • Patent Number Year Symeres Authors Customer
    Imidazo[1,2-a]pyridines as soluble guanylate cyclase stimulators for the treatment of cardiovascular diseases WO2015/165933 A3 2015 Dominika Bachera Bayer Pharma

    Read more

  • Patent Number Year Symeres Authors Customer
    Fused imidazolyl derivatives, their preparation and use as medicaments WO2015091795 2015 Piotr Nieczypor Esteve

    Read more

  • Patent Number Year Symeres Authors Customer
    Process for preparing a urea grease WO2014/122273 A1 2014 Don van Zwieten, Ton Visser Shell

    Read more

  • Patent Number Year Symeres Authors Customer
    Compounds for Protection of Cells WO2014/098586A1 2014 André Heeres, Jean-Paul Seerden Sulfateq BV

    Read more

  • Patent Number Year Symeres Authors Customer
    Chromanyl Derivatives for Treating Mitochondrial Disease WO2014011047A1 2014 Ruben Leenders, Geert Jan Sterk Khondrion

    Read more

  • Patent Number Year Symeres Authors Customer
    Geranyl geranyl acetone analogs and uses therof WO2013157955 A1 2013 André Heeres, Jean-Paul Seerden Nyken Holding B.V., University of Groningen

    Read more

  • Patent Number Year Symeres Authors Customer
    Acetylenic Microbiocides WO 2013 144224 2013 Ruud Titulaer Syngenta

    Read more

Feel free to contact us!

Curious to know more about what can we do for you? Get in touch and let’s start a conversation.

Contact us